0001493152-19-010516.txt : 20190711 0001493152-19-010516.hdr.sgml : 20190711 20190711163105 ACCESSION NUMBER: 0001493152-19-010516 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190711 DATE AS OF CHANGE: 20190711 EFFECTIVENESS DATE: 20190711 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adhera Therapeutics, Inc. CENTRAL INDEX KEY: 0000737207 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112658569 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-344076 FILM NUMBER: 19951425 BUSINESS ADDRESS: STREET 1: 4721 EMPEROR BOULEVARD STREET 2: SUITE 350 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-578-5901 MAIL ADDRESS: STREET 1: 4721 EMPEROR BOULEVARD STREET 2: SUITE 350 CITY: DURHAM STATE: NC ZIP: 27703 FORMER COMPANY: FORMER CONFORMED NAME: Marina Biotech, Inc. DATE OF NAME CHANGE: 20100722 FORMER COMPANY: FORMER CONFORMED NAME: MDRNA, Inc. DATE OF NAME CHANGE: 20080610 FORMER COMPANY: FORMER CONFORMED NAME: NASTECH PHARMACEUTICAL CO INC DATE OF NAME CHANGE: 19920703 D 1 primary_doc.xml X0708 D LIVE 0000737207 Adhera Therapeutics, Inc. 4721 EMPEROR BLVD. SUITE 350 DURHAM NC NORTH CAROLINA 27703 919-578-5901 DELAWARE NASTECH PHARMACEUTICAL CO. INC. Marina Biotech, Inc. MDRNA, Inc. NASTECH PHARMACEUTICAL CO INC Corporation true Nancy Phelan c/o Adhera Therapeutics, Inc. 4721 EMPEROR BLVD., SUITE 350 DURHAM NC NORTH CAROLINA 27703 Executive Officer Director Uli Hacksell c/o Adhera Therapeutics, Inc. 4721 EMPEROR BLVD., SUITE 350 DURHAM NC NORTH CAROLINA 27703 Director Issac Blech c/o Adhera Therapeutics, Inc. 4721 EMPEROR BLVD., SUITE 350 DURHAM NC NORTH CAROLINA 27703 Director Donald A. Williams c/o Adhera Therapeutics, Inc. 4721 EMPEROR BLVD., SUITE 350 DURHAM NC NORTH CAROLINA 27703 Director Tim Boris c/o Adhera Therapeutics, Inc. 4721 EMPEROR BLVD., SUITE 350 DURHAM NC NORTH CAROLINA 27703 Director Erik Emerson c/o Adhera Therapeutics, Inc. 4721 EMPEROR BLVD., SUITE 350 DURHAM NC NORTH CAROLINA 27703 Director Pharmaceuticals Decline to Disclose 06b false 2019-06-28 false true false 10000 Maxim Group LLC 120708 None None 405 LEXINGTON AVE. NEW YORK NY NEW YORK 10174 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA ID IDAHO IL ILLINOIS IN INDIANA KY KENTUCKY MA MASSACHUSETTS MN MINNESOTA MO MISSOURI NV NEVADA NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA PA PENNSYLVANIA SC SOUTH CAROLINA WI WISCONSIN PR PUERTO RICO true 7000000 3239400 3760600 false 45 323940 true 0 Maxim will also receive additional commissions on any future sales in the offering. 0 A Portion of the proceeds may be used for general corporate purposes, including to pay salaries of some related persons listed in Item 3. false Adhera Therapeutics, Inc. /s/ Nancy R. Phelan Nancy R. Phelan Chief Executive Officer 2019-07-11